Clinical trial

Assessment of Trace Elements, Systemic Inflammation and Electrolytes in Patients With Chronic Obstructive Pulmonary Disease

Name
Rasha Abdelfattah
Description
COPD is one of the most common causes of health problems worldwide. It is a disease that is associated with several systemic features that affect its morbidity and mortality.
Trial arms
Trial start
2019-06-01
Estimated PCD
2019-12-01
Trial end
2019-12-15
Status
Completed
Phase
Early phase I
Treatment
Laboratory Tests
Measurement of serum level of CRP, tumor necrosis factor, zinc, copper, potassium, sodium, and magnesium in patients with stable COPD and during exacerbation.
Arms:
Acute exacerbation COPD, COPD patients, healthy controls
Size
140
Primary endpoint
Assessment of the pain resulted in COPD
from baseline to 72 hours
Number of participants with abnormal laboratory test results
from baseline to 48 hours after the taking blood samle
Eligibility criteria
Inclusion Criteria: * COPD patients Exclusion Criteria: * Patients with Cardiovascular diseases, * diabetes mellitus, * chronic kidney disease, * chronic liver disease, * collagen vascular diseases, * cancer, * currently smoking, * current pneumonia or inflammation, or refused to participate in the study
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Measurement of serum level of CRP, tumor necrosis factor, zinc, copper, potassium, sodium, and magnesium in patients with stable COPD and during exacerbation.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 140, 'type': 'ACTUAL'}}
Updated at
2023-02-08

1 organization

1 product

1 indication

Organization
Egymedicalpedia